Rita J Desai

Array ( [id] => 6825649 [patent_doc_number] => 20030236271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Fused heteroaryl derivatives' [patent_app_type] => new [patent_app_number] => 10/459002 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24275 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236271.pdf [firstpage_image] =>[orig_patent_app_number] => 10459002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270424 [patent_doc_number] => 20040058942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcuim channel blockers' [patent_app_type] => new [patent_app_number] => 10/459120 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18843 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058942.pdf [firstpage_image] =>[orig_patent_app_number] => 10459120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150408 [patent_doc_number] => 06770641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Fused heteroaryl derivatives' [patent_app_type] => B2 [patent_app_number] => 10/459220 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23511 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 479 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770641.pdf [firstpage_image] =>[orig_patent_app_number] => 10459220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642316 [patent_doc_number] => 20030212269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => '4.5-disubstituted-2-aminopyrimidines' [patent_app_type] => new [patent_app_number] => 10/457128 [patent_app_country] => US [patent_app_date] => 2003-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14238 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212269.pdf [firstpage_image] =>[orig_patent_app_number] => 10457128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020167 [patent_doc_number] => 20050222186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Substituted diaminopyrimidines' [patent_app_type] => utility [patent_app_number] => 10/517594 [patent_app_country] => US [patent_app_date] => 2003-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10010 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222186.pdf [firstpage_image] =>[orig_patent_app_number] => 10517594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967172 [patent_doc_number] => 20050234069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Novel polymorphs of imatinib mesylate' [patent_app_type] => utility [patent_app_number] => 10/518213 [patent_app_country] => US [patent_app_date] => 2003-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1504 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234069.pdf [firstpage_image] =>[orig_patent_app_number] => 10518213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 641925 [patent_doc_number] => 07122552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Inhibitors of JAK and CDK2 protein kinases' [patent_app_type] => utility [patent_app_number] => 10/449742 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11197 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122552.pdf [firstpage_image] =>[orig_patent_app_number] => 10449742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 745150 [patent_doc_number] => 07026328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins' [patent_app_type] => utility [patent_app_number] => 10/447308 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14153 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026328.pdf [firstpage_image] =>[orig_patent_app_number] => 10447308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 766526 [patent_doc_number] => 07008949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-07 [patent_title] => 'Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins' [patent_app_type] => utility [patent_app_number] => 10/447208 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16728 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/008/07008949.pdf [firstpage_image] =>[orig_patent_app_number] => 10447208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136241 [patent_doc_number] => 20040043989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Gyrase inhibitors and uses thereof' [patent_app_type] => new [patent_app_number] => 10/444588 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16682 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043989.pdf [firstpage_image] =>[orig_patent_app_number] => 10444588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7172818 [patent_doc_number] => 20050203110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Mitotic kinesin inhibitors' [patent_app_type] => utility [patent_app_number] => 10/515284 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23712 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203110.pdf [firstpage_image] =>[orig_patent_app_number] => 10515284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098523 [patent_doc_number] => 20050130982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Oral therapeutic or preventative drugs for pollakiuria and urinary incontinence and oral sleep inducers, containing tropolone derivatives' [patent_app_type] => utility [patent_app_number] => 10/514737 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5679 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130982.pdf [firstpage_image] =>[orig_patent_app_number] => 10514737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680229 [patent_doc_number] => 07084159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases' [patent_app_type] => utility [patent_app_number] => 10/437666 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25542 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084159.pdf [firstpage_image] =>[orig_patent_app_number] => 10437666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 627090 [patent_doc_number] => 07135474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Derivatives of 2-(1-benzyl-1H-pyrazolo(3,4-B)pyridine-3-yl)-5(-4-pyridinyl)l-4-pyrimidinamines and the use thereof as quanylate cyclase stimulators' [patent_app_type] => utility [patent_app_number] => 10/514909 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9007 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135474.pdf [firstpage_image] =>[orig_patent_app_number] => 10514909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543416 [patent_doc_number] => 07166595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Compounds, methods and compositions' [patent_app_type] => utility [patent_app_number] => 10/429195 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38787 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166595.pdf [firstpage_image] =>[orig_patent_app_number] => 10429195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387244 [patent_doc_number] => 20040029887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Acetamides and benzamides that are useful in treating sexual dysfunction' [patent_app_type] => new [patent_app_number] => 10/425152 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 115295 [patent_no_of_claims] => 165 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029887.pdf [firstpage_image] =>[orig_patent_app_number] => 10425152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404186 [patent_doc_number] => 20040023965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Imidazo-triazines as corticotropin releasing factor antagonists' [patent_app_type] => new [patent_app_number] => 10/425310 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45804 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023965.pdf [firstpage_image] =>[orig_patent_app_number] => 10425310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 990805 [patent_doc_number] => 06919332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/424382 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29979 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919332.pdf [firstpage_image] =>[orig_patent_app_number] => 10424382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 928568 [patent_doc_number] => 07314878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders' [patent_app_type] => utility [patent_app_number] => 10/511438 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11403 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314878.pdf [firstpage_image] =>[orig_patent_app_number] => 10511438 [rel_patent_id] =>[rel_patent_doc_number] =>)